Pond Algae Protein Wins the 2026 Nobel Prize

Some Nobel Prizes trace back to a single elegant question. This year’s prize in medicine traces back to a pond, a single-celled green alga, and a scientist who simply wanted to know why it swims toward light.

Three Scientists, One Shared Discovery

The 2026 Nobel Prize in Physiology or Medicine went jointly to Karl Deisseroth, 55, a professor at Stanford University and the Howard Hughes Medical Institute; Peter Hegemann, 72, a professor at Humboldt University in Berlin; and Georg Nagel, 73, a professor at the University of Wurzburg in Germany. The Karolinska Institutet in Stockholm announced the award on October 5, honoring the trio for their discoveries concerning light-gated ion channels and optogenetics, a technique that lets researchers switch individual nerve cells on or off using pulses of light.

An Alga’s Odd Habit

The story starts in the early 1990s at Germany’s Max Planck Institute, where Hegemann became curious about a basic behavioral puzzle: how does Chlamydomonas, a single-celled green alga, manage to swim toward light? Working with Nagel, he eventually found the answer. The alga carries a protein called channelrhodopsin embedded in its cell membrane, a light-sensitive channel that snaps open the instant light hits it. Testing the protein further, the pair discovered something remarkable: channelrhodopsin worked the same way in essentially any cell they injected it into, not just in algae.

From Algae to Living Rat Brains

Deisseroth took that discovery somewhere nobody had taken it before. He introduced the gene for channelrhodopsin directly into nerve cells from rats, and found he could trigger a nerve signal in a living brain simply by shining blue light on it. That gave neuroscientists something they had never had: a way to identify exactly which cells are responsible for specific functions, and how those cells connect to one another, with a level of control previous tools couldn’t match.

Millisecond Precision

“Optogenetics provides opportunities for mapping the brain in a way that we could once only dream of,” said Per Svenningsson, chair of the Nobel Committee for Physiology or Medicine. Speaking with the outlet STAT shortly after the announcement, Deisseroth explained what makes the technique so different from earlier neuroscience tools. “When you think about light in science or light in medicine, you think of it as an observational tool,” he said. “But with optogenetics, it’s the complete opposite of that. We’re not using light to collect information, we’re using light to cause things to happen…it’s using light to turn cells on or off with that millisecond precision and the cellular resolution that is essential to brain function.”

Friends Before Laureates

Deisseroth was the first of the three laureates reached by the Nobel committee. “It was after midnight, and I was just drifting off to sleep,” he said. “It was a very unexpected, but of course very delightful call.” Thomas Perlmann, secretary for the Nobel Committee for Physiology or Medicine, said all three winners reacted the same way when they learned they’d be sharing the prize together, calling each other “my friends.” Deisseroth described Hegemann and Nagel as frequent collaborators over many years. “We’ve written multiple papers together, and sort of shared this journey of discovery over many years,” he said. “We met at conferences, met each other’s families, shared beers at meetings.”

A Name Missing From the List

Nobel rules cap any prize at three recipients, which meant some genuine contributors to optogenetics went unrecognized. Many in the scientific community pointed to Ed Boyden, now at MIT, who was first author on Deisseroth’s landmark 2005 paper and a doctoral student in his lab at the time; Boyden didn’t respond to requests for comment on the omission. The Nobel committee’s own background materials separately credited other researchers, including Austrian neurophysiologist Gero Miesenbock, who achieved the first genetic light-sensitization of non-light-sensing neurons in 2002, and Zhuo-Hua Pan of Wayne State University, who successfully tested channelrhodopsin in retinal ganglion cells in 2004. Deisseroth acknowledged the much larger community behind the work. “We have so many collaborators, colleagues, and students and postdoctoral fellows in the lab over the years,” he said. “It’s been a very broad community, and so many things had to be solved to make everything work and to make the discoveries happen.”

A Tool Still Expanding Its Reach

Jeremy Berg, former editor-in-chief of the journal Science, told STAT he’d followed Deisseroth’s career since his early NIH Director’s Pioneer Award in 2005. “He proposed a vision for optogenetics that was quite compelling and he has developed his ideas remarkably ever since,” Berg said, adding he wasn’t at all surprised the work eventually earned a Nobel Prize. Don Hilgemann, a biophysicist at UT Southwestern who mentored Nagel in the early 1990s, remembered him as “an extremely adventurous experimenter who could quickly master difficult, technically challenging methods.” Since its development, optogenetics has become a standard tool in neuroscience labs worldwide, used to map brain circuits and explore potential treatments for neurological and psychiatric disease. The three laureates will share a prize of 12 million Swedish kronor, roughly 1.2 million dollars.

Sources

This report draws on the Nobel Committee’s own announcement, with original reporting by Annalisa Merelli for STAT News.